Baird Medical Investment Holdin (BDMD) Fair Value 2026

BDMD · Surgical & Medical Instruments & Apparatus ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

2.6 /10

32 fundamental signals · 12 models active

Value Trap Risk

— (—/100)

Quick Summary — As of 2026-07-15, Baird Medical Investment Holdin (BDMD) trades at $1.11, approximately 244% above CirclFi’s Bayesian DCF fair value of $0.32. QOC: 2.6/10. 12/13 models active.

Key Facts

Ticker
BDMD
Price
$1.11
Quality Score
2.6/10
Value Trap Risk
—/100
Models Active
12/13
Last Updated
Strength: First Chicago suggests +62.5% upside with 9% confidence
Risk: Below-average Quality Score of 2.6/10 signals weak fundamentals

Is Baird Medical Investment Holdin (BDMD) Undervalued or Overvalued in 2026?

According to CirclFi’s 12-model valuation engine, Baird Medical Investment Holdin (BDMD) appears overvalued as of : the median of 12 independent fair value estimates is $0.74, 33.5% below the current price of $1.11. Estimates range from $0.13 to $2.81. BDMD scores 2.6/10 on fundamental quality and —/100 on value-trap risk.

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Baird Medical Investment Holdin Stock in 2026? →

Valuation Matrix

12 Intrinsic Value Models vs. Current Price ($1.11)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
Low Conviction
 $0.32 -70.9%
Earnings Power Value
Low Conviction
 $0.18 -83.5%
CUCE Ensemble
Low Conviction
 $1.20 +7.8%
First Chicago
Low Conviction
 $1.80 +62.5%

Unlock the Full Matrix

Access 8 additional models including EROIC Spread, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 12 Models →

Cancel anytime · No contracts · Instant access

What Is Baird Medical Investment Holdin (BDMD) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on Baird Medical Investment Holdin at its current price of $1.11. The composite intrinsic value is estimated at $0.99 (-10.7% average return), with 7 models flagging overvaluation risk. The most optimistic model, Regime Cross, places fair value at $2.81 (+152.8%), while EROIC — the most conservative — estimates $0.13 (-88.6%). This +241.3% gap reflects genuine analytical uncertainty about Baird Medical Investment Holdin's intrinsic worth.

What Do the Models Say About BDMD?

12 of 13 models are currently active for BDMD. Of these, 5 models suggest upside while 7 models suggest overvaluation. The Bayesian DCF estimates BDMD's intrinsic value at $0.32, implying -70.9% downside from the current price. See which stocks rank higher →

How Does BDMD Rank in Surgical & Medical Instruments & Apparatus?

Among 109 Surgical & Medical Instruments & Apparatus stocks, BDMD ranks #104 by Quality of Company score. CirclFi's QOC score of 2.6/10 evaluates 32 fundamental signals. A score of 2.6 signals below-average fundamentals.

See all Most Undervalued Surgical & Medical Instruments & Apparatus Stocks →

Baird Medical Investment Holdin operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is BDMD a Value Trap?

The Value Trap algorithm is not active for BDMD. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

12 of 13 models are active for Baird Medical Investment Holdin. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Baird Medical Investment Holdin is rated at 2.6/10. This weak-tier score exhibits fundamental weaknesses that warrant careful scrutiny.

The gap between the most bullish and bearish model spans +241.3% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every BDMD valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across BDMD's 12 active models, average confidence is 14%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Baird Medical Investment Holdin Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Surgical & Medical Instruments & Apparatus Stocks Should You Also Analyze?

8 related Surgical & Medical Instruments & Apparatus stocks with 13-model coverage

DXCMDexCom, Inc.QOC 10.0IRMDiRadimed CorporationQOC 10.0PODDInsulet CorporationQOC 10.0RMDResMed Inc.QOC 10.0WSTWest Pharmaceutical Services, IQOC 9.9HAEHaemonetics CorporationQOC 9.8LMATLeMaitre Vascular, Inc.QOC 9.8GMEDGlobus Medical, Inc.QOC 9.2

Read investment analysis: DXCM · IRMD · PODD · RMD · WST

See all Surgical & Medical Instruments & Apparatus stocks ranked →

Frequently Asked Questions About Baird Medical Investment Holdin

What is Baird Medical Investment Holdin's intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Baird Medical Investment Holdin (BDMD) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $0.32. The Quality of Company score is 2.6/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is BDMD overvalued or undervalued right now?

At $1.11, 5 of 12 active models suggest BDMD may be undervalued, while 7 indicate potential overvaluation. The median of all 12 fair value estimates is $0.74, 33.5% below the current price of $1.11 — a consensus view that BDMD is overvalued. The assessment depends on which methodology best fits Baird Medical Investment Holdin's business model in Surgical & Medical Instruments & Apparatus.

What does a Quality of Company score of 2.6 mean for BDMD?

Baird Medical Investment Holdin's QOC of 2.6/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on BDMD?

CirclFi analyzes BDMD with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 12 of 13 are active for this stock. Read the full methodology →

Is BDMD a value trap in 2026?

CirclFi's Value Trap algorithm does not have sufficient data for BDMD at this time. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 12-model valuation engine, Baird Medical Investment Holdin (BDMD) has a median fair value of $0.74 — 33.5% below the current price of $1.11 — as of 2026-07-15.” Source: circlfi.com/stock/BDMD/ · Methodology

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 12 mathematical frameworks give you clarity on BDMD.

Unlock All 12 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access